Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data

Diabetes Care. 2023 May 1;46(5):993-997. doi: 10.2337/dc22-2290.

Abstract

Objective: To develop a noninvasive hypoglycemia detection approach using smartwatch data.

Research design and methods: We prospectively collected data from two wrist-worn wearables (Garmin vivoactive 4S, Empatica E4) and continuous glucose monitoring values in adults with diabetes on insulin treatment. Using these data, we developed a machine learning (ML) approach to detect hypoglycemia (<3.9 mmol/L) noninvasively in unseen individuals and solely based on wearable data.

Results: Twenty-two individuals were included in the final analysis (age 54.5 ± 15.2 years, HbA1c 6.9 ± 0.6%, 16 males). Hypoglycemia was detected with an area under the receiver operating characteristic curve of 0.76 ± 0.07 solely based on wearable data. Feature analysis revealed that the ML model associated increased heart rate, decreased heart rate variability, and increased tonic electrodermal activity with hypoglycemia.

Conclusions: Our approach may allow for noninvasive hypoglycemia detection using wearables in people with diabetes and thus complement existing methods for hypoglycemia detection and warning.

Trial registration: ClinicalTrials.gov NCT04689685.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blood Glucose / analysis
  • Blood Glucose Self-Monitoring / methods
  • Diabetes Mellitus, Type 1*
  • Humans
  • Hypoglycemia* / diagnosis
  • Hypoglycemic Agents
  • Insulin
  • Male
  • Middle Aged

Substances

  • Hypoglycemic Agents
  • Blood Glucose
  • Insulin

Associated data

  • ClinicalTrials.gov/NCT04689685